What Do Digital Biomarkers Mean?

[AllBiopro Blog #4] 2017년 세계 매출 상위 5대 백신 회사

[GE Healthcare Life Science] 2018 Laboratory Filtration Product Guide

[Webinar] Is Your Clinical Supply Playbook Ready for Phase II and Beyond?

[AllBiopro Blog #3] 2018년 7월5째주 임상 진행 사항

[Pall] 13 things to consider when selecting your next filter integrity test instrument

[Repligen] Continuous Bioprocessing: A Repligen E-book

[AllBiopro Blog #2] 2018년 7월4째주 임상 진행 사항

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 July 2018

Regulatory Explainer: Everything You Need to Know About FDA’s Priority Review Vouchers

[AllBiopro Blog #1] FDA, 바이오시밀러 활성정책 발표

[Roche] FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency

[IDT] Using a codon optimization tool—how it works and advantages it provides

Could even more cancer patients benefit from PARP inhibitors?

[Pall] Ensure Integrity of Your Single-Use Systems

[Charls River] FROZEN! CRYO-EM GRABS THE LIMELIGHT

[Charles River] Does the Immune System Influence Schizophrenia?

Controlling CRISPR and gene therapy with an amino acid switch

Arming antibiotics with a vaccination-like immune response

[Merck Millipore] Milli-Q® HX 7000 SD All-In-One Water Purification Systems

[Roche] Phase III IMpassion130 study showed Roche’s Tecentriq plus Abraxane significantly reduced the risk of disease worsening or death in people with metastatic triple negative breast cancer